These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9092289)

  • 1. Controversies in women's health maintenance.
    Morrison EH
    Am Fam Physician; 1997 Mar; 55(4):1283-90. PubMed ID: 9092289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer and HRT--what are the data?
    Bieber EJ; Barnes RB
    Int J Fertil Womens Med; 2001; 46(2):73-8. PubMed ID: 11374658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart disease in women.
    Giardina EG
    Int J Fertil Womens Med; 2000; 45(6):350-7. PubMed ID: 11140544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's health issues in a dialysis population.
    Rush H; Neugarten J; Coco M
    Clin Nephrol; 2000 Dec; 54(6):455-62. PubMed ID: 11140806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.
    Hsia J; Kemper E; Kiefe C; Zapka J; Sofaer S; Pettinger M; Bowen D; Limacher M; Lillington L; Mason E
    Prev Med; 2000 Sep; 31(3):261-70. PubMed ID: 10964640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why women still die from cervical cancer.
    Masood S
    J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical decision-making with the woman after menopause.
    Bidikov I; Meier DE
    Geriatrics; 1997 Mar; 52(3):28-35; quiz 36. PubMed ID: 9068621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on women's health: editors' 1997-1998 year in review.
    Freund KM; Pastorek JG
    Medscape Womens Health; 1998 Jan; 3(1):2. PubMed ID: 9732099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.